Unternehmensantwort

Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Gilead Sciences hat nicht geantwortet auf

Prices of AIDS medicines in developing countries continue to be a concern

Story 28 Jun 2005

Zeitleiste

Prices of AIDS medicines in developing countries continue to be a concern

Datum:

28 Jun 2005

Inhaltsart:

Artikel

Verfügbare Sprachen: English
Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Datum:

28 Jun 2005

Inhaltsart:

Unternehmensantwort

Verfügbare Sprachen: English

Vollständige Story anzeigen